Navigation Links
Virginia Woman Suffers Serious Injuries from Her Transvaginal Mesh Device, Alleges Parker Waichman LLP in Lawsuit
Date:9/13/2013

New York, NY (PRWEB) September 13, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by dangerous drugs and defective medical devices, has filed a lawsuit on behalf of a Virginia woman who alleges that a transvaginal mesh implant seriously injured her. The suit was filed on July 10, 2013, in the U.S. District Court for the Southern District of West Virginia (Case No. 2:13-cv-18634) in the Multidistrict Litigation (MDL) entitled In re: C. R. Bard, Inc. Pelvic System Products Liability Litigation, MDL No. 2187. C.R. Bard, Inc., and Sofradim Production SAS have been named as Defendants.

According to the Complaint, the Plaintiff was implanted with the Uretex TO Trans-obturator Urethral Support System on July 25, 2005. The implant was supposed to help treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP), conditions caused by the weakening of the pelvic wall. Transvaginal mesh products are designed to help support the pelvic wall. The lawsuit, however, alleges that the mesh device was defective and had a flawed design that caused serious, and possibly permanent, injuries. The suit further alleges that the Defendants knew about the dangers of their product but chose not to warn consumers.

Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.

The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:

  • Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)
  • Pain
  • Infection
  • Bleeding
  • Pain during sexual intercourse (dyspareunia)
  • Organ perforation
  • Urinary problems

The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP).

The first two bellwether trials in the C.R. Bard MDL ended in favor of the Plaintiffs, according to court documents. In the second bellwether, the parties agreed to settle for an undisclosed amount, according to court documents. The trial began, and was settled on, the same date, Aug. 21, 2013, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Queen v. C.R. Bard Inc., Case No. 2:11-cv-00012).

That settlement occurred about one week after another federal jury awarded a total of $2 million in damages to a Georgia woman, having found that C.R. Bard Inc. had failed to warn of the potential dangers associated with its Avaulta-branded vaginal mesh device, according to court documents. On Thursday, Aug. 15, 2013, the jurors awarded the woman $250,000 in compensatory damages and $1.75 million in punitive damages. The trial had begun on July 29, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195).

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/tvm_crbard_bradenburg/09/prweb11123536.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. CareClix Provides Telemedicine Services to Leading Provider of Warehouse and Shipping Services, Davis Storage of Danville, Virginia
2. Virginia Tech Carilion researchers find surprising relationships in brain signaling
3. Waterproofing Virginia and Water Damage Virginia "Best of the Best" Awarded to Drainage & Erosion Solutions, LLC for Excellence by Follow Media Consulting, Inc.
4. Bodnar Chiropractic Center of Alexandria, VA Receives Top Honors for 2013 from Northern Virginia Magazine
5. Transvaginal Mesh Lawsuit News: New Orders Issued in Vaginal Mesh Litigations Underway in West Virginia Federal Court, Bernstein Liebhard LLP Reports.
6. Skechers Lawsuit Filed by Wright & Schulte Alleges that a Virginia Woman Sustained a Serious, Painful Knee Injury Due to the Dangerous Design of Shape-Ups
7. C.R. Bard Settles Its Second Transvaginal Mesh Case in West Virginia Multidistrict Litigation, Notes Parker Waichman LLP
8. NuvaRing Lawsuit Filed by Alonso Krangle Alleges that a Virginia Woman Developed Pulmonary Embolism Due to NuvaRing Use
9. Women's Strike Force Announces First Fund Distribution to Virginia House of Delegates Candidates for November Race
10. AFrame Digital Selected as Preferred Patient Telemonitoring Solution for Virginia Hospitals
11. Zac Brown Band Tickets Virginia Beach: The Zac Brown Band Adds a Concert Date on October 12, 2013 at the Farm Bureau Live at Virginia Beach, VA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each person ... author, Jerri Broglin, a survivor of great loss who gained insight on how to ... those searching for answers, as we are finding the answers that are so deep ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... ... 24, 2017 , ... Anaconda BioMed, a pre-clinical stage medical ... treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical ... towards regulatory and clinical phases. , "This is another important step for Anaconda ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: